Safety and Efficacy of Endoscopic Ultrasound (EUS) Guided Radiofrequency Ablation (RFA) in the Treatment of Pancreatic Lesions

ConditionPancreatic Cancer

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorThe University of Texas Health Science Center, Houston

About this trial

This is a 7-year prospective single-center registry study to assess the safety and efficacy of Endoscopic Ultrasound (EUS) Guided Radiofrequency Ablation (RFA) in the treatment of pancreatic lesions.

Eligibility criteria

Qualifiers

Diagnosis of any pancreatic pre-malignant lesion and/or pancreatic malignancy

Patients already undergoing EUS-RFA for treatment of pancreatic lesions clinically

Disqualifiers

Patients with co-existing malignancies of other organs (or a prior history of such)

Patients unable to provide informed consent

Patients unable to complete follow-up

Trial design

Treatments tested in this trial

Endoscopic Ultrasound (EUS) Guided Radiofrequency Ablation (RFA)

Treatment groups

60 Participants

are divided into 1 treatment group

Sponsors and collaborators

The University of Texas Health Science Center, Houston

Lead sponsor

Source ClinicalTrials.gov